AbCellera is a privately held technology company with an antibody discovery platform that searches and analyzes natural immune systems to find antibodies that can be used to prevent and treat disease. AbCellera’s technology, which combines high-throughput microfluidics, hyper-scale data science, machine learning, bioinformatics, and genomics, identifies new drug candidates and aims to reduce the time it takes to bring treatments to the clinic. AbCellera's partners include leading biotechnology companies, global health organizations, and many of the top 10 biopharmaceutical companies.
TechnologiesAI Companies (Drug Discovery)
Posts Mentioning This Company
Explore large multidimensional data with Celium™, our proprietary antibody visualization software.
No pipelines published yet
No services posted yet